Morepen Laboratories Ltd Sees Exceptional Volume Surge Amid Positive Momentum

Robust Trading Activity and Volume Analysis

On 17 Sep 2026, Morepen Laboratories Ltd (symbol: MOREPENLAB) emerged as one of the most actively traded stocks by volume on the exchange, with a total traded volume of 1.89 crore shares. This translated into a substantial traded value of approximately ₹224.25 crores, underscoring significant liquidity and investor participation. The stock opened at ₹115.00, up 4.51% from the previous close of ₹114.73, and touched an intraday high of ₹120.90, marking a 4.66% gain during the session. The last traded price (LTP) stood at ₹119.35 as of 12:29 IST, reflecting a day change of 4.01%.

The stock’s trading range was relatively narrow at ₹0.25, indicating concentrated trading activity near the lower end of the day’s price band. Notably, the weighted average price was closer to the day’s low, suggesting that despite the price rally, a significant volume of shares exchanged hands at more conservative price levels, which can be interpreted as a sign of cautious accumulation by investors.

Technical Strength and Moving Averages

Morepen Laboratories is currently trading above all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – signalling a strong bullish trend across multiple timeframes. This technical positioning often attracts momentum traders and institutional investors looking for stocks with sustained upward trajectories. The stock is also trading just 2.23% below its 52-week high of ₹122.55, indicating proximity to a significant resistance level that, if breached, could trigger further upside.

Additionally, the stock has recorded consecutive gains over the past two days, delivering a cumulative return of 12.86% during this period. This positive price action, combined with rising volumes, suggests healthy investor confidence and potential accumulation by market participants.

Delivery Volumes and Investor Participation

One of the most compelling indicators of genuine buying interest is the delivery volume, which represents shares actually taken into investors’ demat accounts rather than intraday speculative trades. On 16 Sep 2026, Morepen Laboratories reported a delivery volume of 1 crore shares, marking a remarkable 115.7% increase compared to its 5-day average delivery volume. This surge in delivery volume is a strong signal of accumulation by long-term investors and institutional players, reinforcing the bullish outlook.

Liquidity remains robust, with the stock’s average traded value over five days supporting trade sizes of up to ₹4.56 crores without significant price impact. This level of liquidity is favourable for both retail and institutional investors seeking to enter or exit positions efficiently.

Comparative Performance and Sector Context

Morepen Laboratories outperformed its Pharmaceuticals & Biotechnology sector, which recorded a modest 1.15% gain on the same day. The stock’s 4.55% one-day return also surpassed the Sensex’s 0.60% increase, highlighting its relative strength in a broadly positive market environment. This outperformance is particularly noteworthy given the stock’s small-cap status and the competitive nature of the pharmaceutical sector.

The company’s market capitalisation stands at ₹6,395 crores, categorising it as a small-cap stock. Despite this, the stock’s recent upgrade in Mojo Grade from Sell to Hold on 3 Aug 2026, with a current Mojo Score of 64.0, reflects improving fundamentals and a more balanced risk-reward profile. This upgrade may have contributed to renewed investor interest and the surge in trading volumes.

Price Action and Investor Sentiment

The stock’s opening gap up of 4.51% on 17 Sep 2026 indicates strong overnight buying interest, possibly driven by positive news flow or technical triggers. The intraday high of ₹120.08 further confirms bullish momentum, although the narrow trading range suggests some profit-taking or cautious positioning near resistance levels. The steady rise over the last two sessions, coupled with increased delivery volumes, points to a constructive accumulation phase rather than speculative frenzy.

Investors should note that the stock’s proximity to its 52-week high could invite volatility as market participants weigh the potential for a breakout against the risk of a pullback. However, the overall technical and volume indicators favour a continuation of the upward trend in the near term.

Outlook and Investor Considerations

Morepen Laboratories’ recent volume surge and price appreciation reflect a positive shift in market sentiment, supported by technical strength and improving fundamentals. The stock’s upgrade to a Hold rating by MarketsMOJO, combined with its strong delivery volumes and proximity to a 52-week high, suggest that investors are increasingly confident in the company’s prospects.

However, given the stock’s small-cap status and the inherent volatility in the pharmaceutical sector, investors should monitor key technical levels and volume trends closely. A sustained breakout above ₹122.55 could open the door to further gains, while any sharp reversal in volume or price may warrant caution.

Overall, Morepen Laboratories presents an intriguing opportunity for investors seeking exposure to the Pharmaceuticals & Biotechnology sector with a stock demonstrating clear signs of accumulation and momentum.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →